WindMIL Therapeutics

0 followers


WindMIL Therapeutics is a clinical stage oncology cell therapy company. The company is leveraging its proprietary platform to develop a novel class of cell therapies called MILs™ (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow.

Industries

Employees

11-50

Links


Org chart

Don Hayden
Chairman & CEO
Collapse
Kimberly Noonan
Evp,cso,founder
Karen Larochelle
SVP, Corporate & Business Development

Board & advisors

Brian Dovey
Director
Anna French
Director
Mark McDade
Director
Howard Soule
Director
Ivan Borrello
Scientific Advisor
Martin J. Edelman
Scientific Advisor
Marcela V. Maus
Scientific Advisor
Drew Pardoll
Scientific Advisor
Jeffrey Weber
Scientific Advisor
Kenneth Anderson
Scientific Advisor